Do elevated urinary tryptophan, 5-HIAA, and xanthurenic acid reflect altered tryptophan handling?

Urinary excretion of tryptophan, 5-hydroxyindoleacetic acid (5-HIAA), and xanthurenic acid serves as a sensitive, functional readout of how the body partitions this essential amino acid between competing biochemical pathways.

Mechanistic pathways

• Gut microbial influence: Gut-derived lipopolysaccharides (LPS) activate host Toll-like receptor 4 (TLR4) signaling to strongly induce indoleamine 2,3-dioxygenase 1 (IDO1). This rate-limiting enzyme diverts tryptophan away from serotonin synthesis and into the kynurenine pathway. Conversely, beneficial gut microbes like Akkermansia muciniphila and their lactate products upregulate tryptophan hydroxylase 1 (TPH1), promoting host serotonin synthesis.
• Vitamin B6 cofactor dependency: The active form of vitamin B6, pyridoxal 5'-phosphate (PLP), is a crucial cofactor for kynureninase (KYNU). Because KYNU has a low affinity for PLP, vitamin B6 deficiency selectively impairs its activity while sparing kynurenine aminotransferase (KAT). This enzymatic mismatch causes the intermediate 3-hydroxykynurenine to accumulate and transaminate into xanthurenic acid.

Clinical and functional biomarkers

• Serotonergic turnover: Urinary 5-HIAA directly reflects systemic serotonin synthesis and turnover, serving as a functional marker for gastrointestinal dysmotility or inflammatory states.
• Nutritional status: Because of the kynureninase block during vitamin B6 deficiency, downstream excretion of xanthurenic acid can increase up to 30-fold following an oral tryptophan load test, making it a highly sensitive diagnostic biomarker for functional B6 insufficiency.

Bottom line

• Elevated urinary tryptophan, 5-HIAA, and xanthurenic acid are highly validated biomarkers that reflect altered host tryptophan handling. These shifts are directly driven by gut microbial signaling (modulating IDO1 and TPH1) and vitamin B6 status (regulating kynureninase activity).